OncoMed Pharmaceuticals Inc. (OMED) Drops 15.49% on January 11

Equities Staff |

OncoMed Pharmaceuticals Inc. (OMED) was one of the Russell 2000's biggest losers for Monday January 11 as the stock slid 15.49% to $17.40, a loss of $-3.19 per share. Starting at an opening price of $20.68 a share, the stock traded between $16.76 and $20.76 over the course of the trading day. Volume was 365,013 shares over 2,950 trades, against an average daily volume of 164,290 shares and a total float of 30.11 million.

The losses send OncoMed Pharmaceuticals Inc. down to a market cap of $523.89 million. In the last year, OncoMed Pharmaceuticals Inc. has traded between $29.83 and $13.33, and its 50-day SMA is currently $21.31 and 200-day SMA is $21.80.

OncoMed Pharmaceuticals Inc is a clinical development-stage biopharmaceutical company focused on discovering and developing novel protein therapeutics targeting cancer stem cells, or CSCs.

OncoMed Pharmaceuticals Inc. is based out of Redwood City, CA and has some 108 employees. Its CEO is Paul J. Hastings.

For a complete fundamental analysis analysis of OncoMed Pharmaceuticals Inc., check out Equities.com’s Stock Valuation Analysis report for OMED. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Reliq Health Technologies Inc.

Moseda Technologies Inc provides mobile and IT cloud computing to increase operational efficiency and security. It develops SmartFleet, a solution designed for commercial use, as well as SmartCare, a mHealth…

Private Markets


A peer-to-Peer authentic photo marketplace disrupting the $10B commercial photography industry.

Dropbox, Inc.

Dropbox is a service that allows their users to bring all photos, docs, and videos anywhere, and share them easily. Any file saved to Dropbox will automatically save to all…